Contracts › 75F40126F19005
75F40126F19005: Ddi Clinical Pharmacology Study
Awarded to Tranquil Clinical and Research Consulting Services Llc by Food and Drug Administration (FDA).
$1.6Mobligated
$1.6Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126F19005 |
|---|---|
| Vehicle | 75F40125D00003 |
| Awardee | Tranquil Clinical and Research Consulting Services Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AJ12 General Science and Technology R&D Services; General Science and Technology; Applied Research |
| Place of performance | TX |
| Period of performance | 30 September 2026 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record